Venus Concept (VERO) Announces Proposed Public Offering of Common Stock, Warrants

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering pursuant to its existing shelf registration statement. All of the common stock and warrants to be sold in the proposed offering are to be sold by Venus Concept. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Venus Concept intends to use the net proceeds from the proposed offering for general corporate purposes, including the funding of research and development activities.

Oppenheimer & Co. Inc. is acting as sole book-running manager and Ladenburg Thalmann & Co. Inc. is acting as lead manager of the proposed offering.

You May Also Be Interested In

• Zenas BioPharma (ZBIO) files for up to 7M share offering by selling stockholders
• Ladenburg Thalmann Starts Hawaiian Electric (HE) at Sell
• CPI Card Group shareholders price secondary offering at $21.50 per share